Boone, Megann A. http://orcid.org/0000-0002-7806-8027
Taslim, Cenny
Crow, Jesse C.
Selich-Anderson, Julia
Byrum, Andrea K.
Showpnil, Iftekhar A.
Sunkel, Benjamin D. http://orcid.org/0000-0003-1376-9567
Wang, Meng
Stanton, Benjamin Z. http://orcid.org/0000-0002-2613-2955
Theisen, Emily R. http://orcid.org/0000-0003-2923-1198
Lessnick, Stephen L. http://orcid.org/0000-0001-9645-4434
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (T32 GM068412, T32 GM068412)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 8 November 2020
Revised: 19 May 2021
Accepted: 28 May 2021
First Online: 18 June 2021
Competing interests
: Research reported in this publication was supported by the National Institute of Health award T32 GM068412 to MAB, and U54 CA231641 to SLL. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SLL declares a competing interest as a member of the advisory board for Salarius Pharmaceuticals. SLL is also a listed inventor on United States Patent No. US 7,939,253 B2, “Methods and compositions for the diagnosis and treatment of Ewing’s sarcoma,” and United States Patent No. US 8,557,532, “Diagnosis and treatment of drug-resistant Ewing’s sarcoma.” This does not alter our adherence to <i>Oncogene</i> policies on sharing data and materials.